| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Imatinib Mesylate | FAERS: 4 | US FAERS | |
| 2 | Carbamazepine | FAERS: 3 | US FAERS | |
| 3 | regorafenib | FAERS: 3 | US FAERS | |
| 4 | Bosentan | FAERS: 1 | US FAERS | |
| 5 | Ergocalciferols | FAERS: 1 | US FAERS | |
| 6 | Fingolimod Hydrochloride | FAERS: 1 | US FAERS | |
| 7 | Insulin Glargine | FAERS: 1 | US FAERS | |
| 8 | Irbesartan | FAERS: 1 | US FAERS | |
| 9 | Losartan | FAERS: 1 | US FAERS | |
| 10 | telithromycin | FAERS: 1 | OFFSIDES US FAERS | |
| 11 | Busulfan | OFFSIDES | ||
| 12 | Calcium Citrate | OFFSIDES | ||
| 13 | Etodolac | OFFSIDES | ||
| 14 | Leflunomide | OFFSIDES | ||
| 15 | Mefloquine | OFFSIDES | ||
| 16 | Oseltamivir | OFFSIDES | ||
| 17 | Ribavirin | OFFSIDES | ||
| 18 | Rifampin | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.